SCHEMBL28265692

SCHEMBL28265692

Cc1cc(C)cc(-c2cc(NCC(C)(C)N)nc(N)n2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 10/20 0.46
TLR8 Q9NR97 2/20 0.43
AURKA O14965 2/20 0.41
PDPK1 O15530 2/20 0.41
TGFBR1 P36897 2/20 0.41
AURKB Q96GD4 2/20 0.41
ROCK1 Q13464 2/20 0.37
PRKCA P17252 2/20 0.37
PRKCH P24723 2/20 0.37
PRKCE Q02156 2/20 0.37
PRKCQ Q04759 2/20 0.37
PRKCD Q05655 2/20 0.37
ROCK2 O75116 1/20 0.37
PRKCB P05771 1/20 0.37
PKN1 Q16512 1/20 0.37
PKN2 Q16513 1/20 0.37
NUDT1 P36639 1/20 0.37
LATS1 O95835 1/20 0.36
HEXA P06865 1/20 0.36
HEXB P07686 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28043722 0.90 NUDT1 (0.48) HRH4TLR8AURKAPDPK1TGFBR1
SCHEMBL28043759 0.86 HRH4 (0.43) HRH4TLR8AURKAPDPK1TGFBR1
SCHEMBL28151149 0.83 HRH4 (0.64) HRH4TLR8AURKAPDPK1TGFBR1
SCHEMBL28043772 0.82 AURKA (0.54) HRH4TLR8AURKAPDPK1TGFBR1
SCHEMBL28265745 0.81 HRH4 (0.42) HRH4TLR8AURKAPDPK1TGFBR1
SCHEMBL28043930 0.79 HRH4 (0.55) HRH4TLR8AURKAPDPK1TGFBR1
SCHEMBL28845266 0.78 CYP2D6 (0.55) HRH4TLR8AURKAPDPK1TGFBR1
SCHEMBL28152094 0.78 HRH4 (0.54) HRH4TLR8AURKAPDPK1TGFBR1
SCHEMBL28267183 0.78 HRH4 (0.47) HRH4TLR8AURKAPDPK1TGFBR1
SCHEMBL28043727 0.77 HRH4 (0.56) HRH4TLR8AURKAPDPK1TGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105143206-B Pyrimidine -2,4- diamine derivative for treating cancer 托马斯·黑勒戴药物研究基金会 2019-01-15 CN disclosed